Study of fluoroquinolones resistance in rifampicin‐resistant tuberculosis patients in Beijing: Characteristics, trends, and treatment outcomes

Study of fluoroquinolones resistance in rifampicin‐resistant tuberculosis patients in Beijing: Characteristics, trends, and treatment outcomes

Abstract Background China is a high‐burden country for multidrug‐resistant tuberculosis/rifampin‐resistant tuberculosis (MDR/RR‐TB). Fluoroquinolones (FQs) are key drugs for the treatment of patients with MDR/RR‐TB. However, research on the resistance of FQs in Beijing is limited. Methods We collect...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Nenhan, Tian Lili, Zhao Yanfeng, Chen Shuangshuang, Tao LiYing, Li Qiao, Li Chuanyou, Dai Xiaowei
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Animal Models and Experimental Medicine
Subjects:
drug resistance
levofloxacin
moxifloxacin
mycobacterium tuberculosis
pre‐XDR‐TB
Online Access:https://doi.org/10.1002/ame2.12505
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ame2.12505

Similar Items